Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 48 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8252538

    MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  2. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  3. US 8241863

    Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  4. US 8236335

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  5. US 8232320

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  6. US 8227443

    Silencing of CSN5 gene expression using interfering RNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  7. US 8227188

    Enhancement of influenza gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  8. US 8222222

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  9. US 8221138

    Audio jack connector with improved soldering tail

    Hon Hai Precision Ind. Co., Ltd. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  10. US 8217158

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  11. US 8212007

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  12. US 8212010

    Sphingosine 1-phosphate antagonism

    Expression Drug Designs, LLC · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  13. US 8202980

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  14. US 8197818

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

  15. US 8187606

    HPV antigen fusion protein vaccine compositions and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted May 29, 2012 · Expires May 24, 2032

    granted

  16. US 8182807

    Method for inhibiting reperfusion injury in the brain

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted May 22, 2012 · Expires May 17, 2032

    granted

  17. US 8183009

    Assaying cellular markers for the evaluation of tumors

    Precision Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  18. US 8183362

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  19. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  20. US 8173120

    Method of preventing reduced feed intake in animals and treatment of disease conditions

    Precision Nutrition Pty Ltd · Granted May 8, 2012 · Expires May 3, 2032

    granted

  21. US 8173134

    ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

    Five Prime Therapeutics, Inc. · Granted May 8, 2012 · Expires May 3, 2032

    granted

  22. US 8173602

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

    granted

  23. US 8168415

    Axl fusion proteins as Axl tyrosine kinase inhibitors

    The Regents of the University of Colorado · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

  24. US 8168775

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.